OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer
Shouping Xu, Peiyuan Wang, Jian Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 114
Shouping Xu, Peiyuan Wang, Jian Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 114
Showing 1-25 of 114 citing articles:
Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases
Jinrong Bai, Yunsen Zhang, Ce Tang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110985-110985
Open Access | Times Cited: 471
Jinrong Bai, Yunsen Zhang, Ce Tang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110985-110985
Open Access | Times Cited: 471
A Compressive Review about Taxol®: History and Future Challenges
Julia Gallego‐Jara, Gema Lozano Terol, Rosa Alba Sola Martínez, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5986-5986
Open Access | Times Cited: 244
Julia Gallego‐Jara, Gema Lozano Terol, Rosa Alba Sola Martínez, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5986-5986
Open Access | Times Cited: 244
LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway
Kun Qiao, Shipeng Ning, Lin Wan, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 158
Kun Qiao, Shipeng Ning, Lin Wan, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 158
Noncoding RNAs regulate alternative splicing in Cancer
Yunze Liu, Xin Liu, Changwei Lin, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 129
Yunze Liu, Xin Liu, Changwei Lin, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 129
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 113
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 113
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 96
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 96
Mechanisms of Long Non-Coding RNAs in Cancers and Their Dynamic Regulations
Xiaozhen Zhang, Hao Liu, Su‐Ren Chen
Cancers (2020) Vol. 12, Iss. 5, pp. 1245-1245
Open Access | Times Cited: 118
Xiaozhen Zhang, Hao Liu, Su‐Ren Chen
Cancers (2020) Vol. 12, Iss. 5, pp. 1245-1245
Open Access | Times Cited: 118
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA
Wei Wang, Wentao Hu, Ya Wang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 104
Wei Wang, Wentao Hu, Ya Wang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 104
Long non-coding RNAs are involved in alternative splicing and promote cancer progression
Jiawei Ouyang, Yu Zhong, Yijie Zhang, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 8, pp. 1113-1124
Open Access | Times Cited: 87
Jiawei Ouyang, Yu Zhong, Yijie Zhang, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 8, pp. 1113-1124
Open Access | Times Cited: 87
Progress of Breast Cancer basic research in China
Xuerong Wang, Chao Wang, Jiaheng Guan, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 8, pp. 2069-2079
Open Access | Times Cited: 74
Xuerong Wang, Chao Wang, Jiaheng Guan, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 8, pp. 2069-2079
Open Access | Times Cited: 74
LncRNAs in breast cancer: a link to future approaches
Nikolaos Sideris, Paola Dama, Salih Bayraktar, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1866-1877
Open Access | Times Cited: 51
Nikolaos Sideris, Paola Dama, Salih Bayraktar, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1866-1877
Open Access | Times Cited: 51
Targeting lncRNA DDIT4‐AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 38
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 38
Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy
Mohamed J. Saadh, Mohammad Ali Abdullah Almoyad, Meryelem Tania Churampi Arellano, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 439-453
Closed Access | Times Cited: 23
Mohamed J. Saadh, Mohammad Ali Abdullah Almoyad, Meryelem Tania Churampi Arellano, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 439-453
Closed Access | Times Cited: 23
Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine
Shahab Ur Rehman, Numan Ullah, Zhenbin Zhang, et al.
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 12
Shahab Ur Rehman, Numan Ullah, Zhenbin Zhang, et al.
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 12
Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy
Qinghai Zeng, Jianye Liu, Peiguo Cao, et al.
Clinical Cancer Research (2017) Vol. 24, Iss. 2, pp. 445-459
Open Access | Times Cited: 71
Qinghai Zeng, Jianye Liu, Peiguo Cao, et al.
Clinical Cancer Research (2017) Vol. 24, Iss. 2, pp. 445-459
Open Access | Times Cited: 71
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer
Jian Zhang, Shiyao Sui, Hao Wu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 56
Jian Zhang, Shiyao Sui, Hao Wu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 56
LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma
Lirong Peng, Yiyin Chen, Qiaoping Ou, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107071-107071
Closed Access | Times Cited: 56
Lirong Peng, Yiyin Chen, Qiaoping Ou, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107071-107071
Closed Access | Times Cited: 56
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN
Lei Yang, Yi Chen, Ning Liu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 49
Lei Yang, Yi Chen, Ning Liu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 49
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
Pingting Ye, Lei Feng, Shuo Shi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2101-2101
Open Access | Times Cited: 35
Pingting Ye, Lei Feng, Shuo Shi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2101-2101
Open Access | Times Cited: 35
Mechanisms of non-coding RNA-modulated alternative splicing in cancer
Xiaolin Wang, Jinghan Hua, Jingxin Li, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 541-547
Open Access | Times Cited: 30
Xiaolin Wang, Jinghan Hua, Jingxin Li, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 541-547
Open Access | Times Cited: 30
Transcriptional and Post-Transcriptional Regulation of Autophagy
Qiuqin Ma, Shihui Long, Zhending Gan, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 441-441
Open Access | Times Cited: 29
Qiuqin Ma, Shihui Long, Zhending Gan, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 441-441
Open Access | Times Cited: 29
Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword
Yunchao Zhang, Jiayu Tang, Cheng Wang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 367-381
Open Access | Times Cited: 20
Yunchao Zhang, Jiayu Tang, Cheng Wang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 367-381
Open Access | Times Cited: 20
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
Wenjie Xia, Wuzhen Chen, Chao Ni, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 20
Wenjie Xia, Wuzhen Chen, Chao Ni, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 20
The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer
Min Liu, Subo Zhang, Heng Zhou, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2616-2631
Open Access | Times Cited: 18
Min Liu, Subo Zhang, Heng Zhou, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2616-2631
Open Access | Times Cited: 18
